[Treatment of evolutive chronic polyarthritis with chrysotherapy. Reports. Conclusions. Summaries].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006046:Gold / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007270:Injections, Intra-Articular; D007273:Injections, Intramuscular; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000188:drug therapy; D012871:Skin Diseases / Q000139:chemically induced
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D006046:Gold; D011241:Prednisone
Traitement de la polyarthrite chronique évolutive par la chrysothérapie. Rapports. Conclusions. Résumés.